Vasant Prakash Gandhi
Chief Executive Officer en Molecular Decisions Strategy LLC .
Perfil
Vasant Prakash Gandhi is currently the Chief Executive Officer at Molecular Decisions Strategy LLC.
Previously, he worked as Senior Counsel at Amgen, Inc. and Immunex Corp.
He also served as Chief Strategy Officer & Executive Vice President at ApoVax, Inc., Vice President-Strategic Operations at Abraxis BioScience, Inc., and EVP-Corporate Business Development at Avesthagen Ltd.
Gandhi holds a doctorate degree from Loyola University of Chicago and an undergraduate degree from the University of Illinois.
Cargos activos de Vasant Prakash Gandhi
Empresas | Cargo | Inicio |
---|---|---|
Molecular Decisions Strategy LLC | Chief Executive Officer | - |
Antiguos cargos conocidos de Vasant Prakash Gandhi.
Empresas | Cargo | Fin |
---|---|---|
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 30/03/2011 |
AMGEN INC. | General Counsel | 01/06/2007 |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | General Counsel | 01/07/2002 |
Avesthagen Ltd.
Avesthagen Ltd. Miscellaneous Commercial ServicesCommercial Services Avesthagen Ltd. provides personalized healthcare through convergence of food, pharma and population genetics. It offers genome analysis, transcriptome analysis, metabolome analysis and lead optimization, and recombinant protein expression services, as well as engages in the generation of stable mammalian cell lines over-expressing a recombinant protein, development of product specific bioassays, and design of novel animal component free production media. The company was founded by Villoo Morwala Zareer Patell on April 20, 1998 and is headquartered in Bangalore, India. | Corporate Officer/Principal | - |
ApoVax, Inc.
ApoVax, Inc. Medical/Nursing ServicesHealth Services ApoVax, Inc. developed immunotherapies and therapeutic vaccines. It was a biotechnology company that developed novel immunotherapies, which are treatments based on regulating the host immune system to fight disease. The firm was a scientific foundation that built on two platform technologies that are used to modulate the immune system-ProtEx and ApoVax. The company was founded by Haval Shirwan in 2001 and was headquartered in Louisville, KY. | Corporate Officer/Principal | - |
Formación de Vasant Prakash Gandhi.
Loyola University of Chicago | Doctorate Degree |
University of Illinois | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
AMGEN INC. | Health Technology |
Empresas privadas | 5 |
---|---|
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
ApoVax, Inc.
ApoVax, Inc. Medical/Nursing ServicesHealth Services ApoVax, Inc. developed immunotherapies and therapeutic vaccines. It was a biotechnology company that developed novel immunotherapies, which are treatments based on regulating the host immune system to fight disease. The firm was a scientific foundation that built on two platform technologies that are used to modulate the immune system-ProtEx and ApoVax. The company was founded by Haval Shirwan in 2001 and was headquartered in Louisville, KY. | Health Services |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
Avesthagen Ltd.
Avesthagen Ltd. Miscellaneous Commercial ServicesCommercial Services Avesthagen Ltd. provides personalized healthcare through convergence of food, pharma and population genetics. It offers genome analysis, transcriptome analysis, metabolome analysis and lead optimization, and recombinant protein expression services, as well as engages in the generation of stable mammalian cell lines over-expressing a recombinant protein, development of product specific bioassays, and design of novel animal component free production media. The company was founded by Villoo Morwala Zareer Patell on April 20, 1998 and is headquartered in Bangalore, India. | Commercial Services |
Molecular Decisions Strategy LLC |
- Bolsa de valores
- Insiders
- Vasant Prakash Gandhi